18H0

PreveCeutical Medical Inc

Healthcare · EUR · F

18H0

Price

€0.013

+0.00%

Cap

€7.78M

Earnings

30d Trend

+18.2%

18H0
Loading chart data...
0 days · % change from startPowered by Brain47
VolatilityHigh

550% annualised over 90 days

BRAIN47 SIGNAL

0
WEAK
Risk Level66
Quality20
Momentum24
Technical61
Fundamentals15

Raw weighted: 33×Macro 0.99 (1%)=33

RISK

66/100
90d Volatility
550.0%High
ATR %
0.0%Low daily moves
Max Drawdown (1Y)
-93.3%Volatile

QUALITY

20/100
ROE (avg)
0.0%Weak
Piotroski F-Score
2/9Weak
Accruals
2.0%Accrual heavy

MOMENTUM

24/100
12-1M Momentum
-56.3%Strong downtrend
6-1M Momentum
+0.0%Flat
1M Return
+18.2%Strong recent gains

TECHNICAL

61/100
RSI (14)
63.8Neutral
Price vs SMA200
+30.0%Bullish trend
MACD
0.00Bearish momentum
Bollinger Band
Infinity%Near upper band
SMA Cross
Death CrossDeath Cross
Trend Quality (KER)
1.000Clean trend

FUNDAMENTALS

15/100
P/S
1973.4Expensive

Macro: neutral (×0.99) - Fear/Greed: 64 (Greed) - Data: 100%

Running historical backtest...

BRAIN47 HORIZON ANALYSIS

<3 months62
3-12 months62
1-5+ years21

Limited short-term thesis

BRAIN47'S ASSESSMENT

I rate PreveCeutical Medical Inc at 33/100 — a WEAK reading on the Brain47 Signal. The strongest factor is technical at 61/100. I classify this as a speculative position with the strongest thesis on a short-term horizon.

PAST PERFORMANCE

1 MONTH

+18.2%

3 MONTHS

+8.3%

12 MONTHS

-38.1%

Trailing returns — past performance, not a projection.

DETAILED ANALYSIS

Limited short-term thesis. Technical (61) and low-risk profile are the primary strengths. I note that fundamentals is the weakest area at 15/100 — this warrants monitoring. Historical volatility is elevated at 550%. I classify this as a speculative position — elevated volatility at 550% and smaller market cap define the opportunity.

speculativeScore: 33/100

Want full analysis on every stock?

Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.

Join Brain47 — Free

Generated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.